MARY KATHRYN ALDERSON, MD
Neurology at 5900, Salt Lake City, UT
License number
Utah 167897-1205
Category
Neurology
Type
Neurology
Address
Address
166 E 5900 S STE B106, Salt Lake City, UT 84107
Phone
(801) 743-6444
(801) 743-6888 (Fax)
(801) 262-3441
(801) 269-9005 (Fax)
(801) 743-6888 (Fax)
(801) 262-3441
(801) 269-9005 (Fax)
Personal information
See more information about MARY KATHRYN ALDERSON at radaris.comName
Address
Phone
4242 S Park Terrace Dr, Salt Lake City, UT 84124
Professional information
Dr. Mary K Alderson, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Clinical Neurophysiology
Address:
2875 Decker Lake Dr SUITE 550, Salt Lake City 84119
166 E 5900 S SUITE B106, Murray 84107
(801) 743-6444 (Phone), (801) 743-6888 (Fax)
166 E 5900 S SUITE B106, Murray 84107
(801) 743-6444 (Phone), (801) 743-6888 (Fax)
Languages:
English
Education:
Medical School
University of California At Los Angeles
Graduated: 1981
University of California At Los Angeles
Graduated: 1981
Mary Kathryn Alderson, Salt Lake City UT
Specialties:
Neurology, Clinical Neurophysiology
Work:
Western Neurological Assoc Inc
166 E 5900 S, Salt Lake City, UT 84107
166 E 5900 S, Salt Lake City, UT 84107
Education:
University of California at Los Angeles (1981)
Deletion In Chromosome 17P11.2-12 Which Causes The Disorder Hereditary Neuropathy With Liability To Pressure Palsies
US Patent:
5645993, Jul 8, 1997
Filed:
May 18, 1995
Appl. No.:
8/443561
Inventors:
Phillip F. Chance - Philadelphia PA
Mary Kathryn Alderson - Salt Lake City UT
Shannon J. Odelberg - Salt Lake City UT
M. William Lensch - Devon PA
Mary Kathryn Alderson - Salt Lake City UT
Shannon J. Odelberg - Salt Lake City UT
M. William Lensch - Devon PA
Assignee:
University of Utah - Salt Lake City UT
International Classification:
C12Q 168, C12P 1934, C07H 2104, C12N 1500
US Classification:
435 6
Abstract:
A method is disclosed for diagnosing Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). A submicroscopic deletion of about 1. 5 million basepairs on chromosome 17p11. 2 is associated with the disorder in three unrelated pedigrees. The deletion includes all the markers known to map within the Charcot-Marie-Tooth type 1A (CMT1A) duplication. The method involves detecting the presence or absence of the deletion in DNA extracted from a patient sample. The deletion may be detected by Southern analysis or fluorescence in situ hybridization analysis (FISH). Sequences or probes that may be used to detect the deletion are provided, as are components of a kit for diagnosing HNPP.